NO941073L - Phenylglycinamide of heterocyclic substituted phenylacetic acid derivatives - Google Patents
Phenylglycinamide of heterocyclic substituted phenylacetic acid derivativesInfo
- Publication number
- NO941073L NO941073L NO941073A NO941073A NO941073L NO 941073 L NO941073 L NO 941073L NO 941073 A NO941073 A NO 941073A NO 941073 A NO941073 A NO 941073A NO 941073 L NO941073 L NO 941073L
- Authority
- NO
- Norway
- Prior art keywords
- carbon atoms
- stands
- branched alkyl
- hydrogen
- straight chain
- Prior art date
Links
- 125000000623 heterocyclic group Chemical group 0.000 title abstract 3
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical class OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 title abstract 2
- GXBRYTMUEZNYJT-UHFFFAOYSA-N 2-anilinoacetamide Chemical compound NC(=O)CNC1=CC=CC=C1 GXBRYTMUEZNYJT-UHFFFAOYSA-N 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 11
- 125000000217 alkyl group Chemical group 0.000 abstract 6
- 229910052739 hydrogen Inorganic materials 0.000 abstract 6
- 239000001257 hydrogen Substances 0.000 abstract 6
- 150000002431 hydrogen Chemical class 0.000 abstract 4
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 3
- 229910052736 halogen Inorganic materials 0.000 abstract 3
- 150000002367 halogens Chemical class 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- -1 nitro, hydroxy Chemical group 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 125000005010 perfluoroalkyl group Chemical group 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/68—Halogen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Fenylglycinaraider av heterocyklisk substituerte fenyleddiksyrederivater, med den generelle formel (I) hvor A står for rettkjedet eller forgrenet alkyl eller alkenyl med opptil 8 karbonatomer, eller for cykloalkyl med 3 til 8 karbonatomer, B står for hydrogen, halogen eller for perfluoralkyl med opptil 5 karbonatomer, D står for en gruppe med formelen -CHo-OR^ eller -CO- R7, E står for hydrogen, halogen, nltro, hydroksy, trifluormetyl, trlfluormetoksy, rettkjedet eller forgrenet alkyl, alkoksy eller alkoksykarbonyl med opptil 6 karbonatomer, cyano eller karboksy, L står for hydrogen eller rettkjedet eller forgrenet alkyl med opptil 4 karbonatomer, R1 står for cykloalkyl med 3 til 8 karbonatomer, eller for rettkjedet eller forgrenet alkyl med opptil 8 karbonatomer, som eventuelt er substituert, R2 står for hydrogen eller for rettkjedet eller forgrenet alkyl med opptil 6 karbonatomer, R3 står for hydrogen, hydroksy, halogen eller for rettkjedet eller forgrenet alkoksy med opptil 6 karbonatomer, R4 og R5 er like eller forskjellige og står for hydrogen, fenyl, pyridyl, cykloalkyl med 3 til 8 karbonatomer, eller for rettkjedet eller forgrenet alkyl med opptil 8 karbonatomer, som eventuelt er substituert, eller R4 og R5 danner sammen med nitrogenatomet en 6-med- lemmers mettet heteroring med opptil 3 heteroatomer fra rekken S, N eller O og deres salter. Det blir også beskrevet fremgangsmåter for fremstilling av disse stoffene samt deres anvendelse som virkestoff i legemidler.Phenylglycinaraides of heterocyclic substituted phenylacetic acid derivatives, of the general formula (I) wherein A represents straight or branched alkyl or alkenyl of up to 8 carbon atoms, or of cycloalkyl of 3 to 8 carbon atoms, B stands for hydrogen, halogen or perfluoroalkyl of up to 5 carbon atoms , D stands for a group of the formula -CHO-OR4 or -CO- R7, E stands for hydrogen, halogen, nitro, hydroxy, trifluoromethyl, trifluoromethoxy, straight-chain or branched alkyl, alkoxy or alkoxycarbonyl of up to 6 carbon atoms, cyano or carboxy , L stands for hydrogen or straight chain or branched alkyl of up to 4 carbon atoms, R1 stands for cycloalkyl of 3 to 8 carbon atoms, or for straight chain or branched alkyl of up to 8 carbon atoms optionally substituted, R2 stands for hydrogen or for straight chain or branched alkyl of up to 6 carbon atoms, R 3 represents hydrogen, hydroxy, halogen or straight chain or branched alkoxy of up to 6 carbon atoms, R 4 and R 5 are the same or different and represent hydrogen, phenyl, pyridyl, cycloalkyl of 3 to 8 carbon atoms, or of straight chain or branched alkyl of up to 8 carbon atoms optionally substituted, or R 4 and R 5 form together with the nitrogen atom a 6-member saturated heterocycle with up to 3 heteroatoms from series S, N or O and their salts. Methods are also described for the preparation of these substances as well as their use as active substances in pharmaceuticals.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4309968A DE4309968A1 (en) | 1993-03-26 | 1993-03-26 | Phenylglycinamides of heterocyclic substituted phenylacetic acid derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO941073D0 NO941073D0 (en) | 1994-03-24 |
| NO941073L true NO941073L (en) | 1994-09-27 |
Family
ID=6484001
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO941073A NO941073L (en) | 1993-03-26 | 1994-03-24 | Phenylglycinamide of heterocyclic substituted phenylacetic acid derivatives |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0622358A1 (en) |
| JP (1) | JPH06329637A (en) |
| KR (1) | KR940021532A (en) |
| CN (1) | CN1102645A (en) |
| AU (1) | AU5788694A (en) |
| CA (1) | CA2119669A1 (en) |
| CZ (1) | CZ71094A3 (en) |
| DE (1) | DE4309968A1 (en) |
| FI (1) | FI941380A7 (en) |
| HU (1) | HUT68514A (en) |
| IL (1) | IL109093A0 (en) |
| NO (1) | NO941073L (en) |
| NZ (1) | NZ260163A (en) |
| SK (1) | SK35094A3 (en) |
| ZA (1) | ZA942119B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2219944A1 (en) * | 1995-05-19 | 1996-11-21 | Miho Kobayashi | 2-hydroxyphenylalkylamine derivatives and maillard reaction inhibitors |
| DE19613550A1 (en) * | 1996-04-04 | 1997-10-09 | Bayer Ag | New pyrimido [1,2-a] indoles |
| DE19619950A1 (en) | 1996-04-17 | 1997-10-23 | Bayer Ag | Heterocyclic substituted phenylglycinolamides |
| EP0802192A1 (en) * | 1996-04-17 | 1997-10-22 | Bayer Ag | Heterocyclic-substituted phenylglycinolamides with antiatheroschlerotic activity and process for their production |
| DE19615265A1 (en) * | 1996-04-18 | 1997-12-04 | Bayer Ag | New pyridazino, pyrimido, pyrazino and triazinoindoles |
| EP1013273A1 (en) * | 1998-12-23 | 2000-06-28 | Novartis AG | Use of AT-1 receptor antagonist or AT-2 receptor modulator for treating diseases associated with an increase of AT-1 or AT-2 receptors |
| ATE524176T1 (en) * | 1998-12-23 | 2011-09-15 | Novartis Pharma Gmbh | VALSARTAN TABLET |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0515548A4 (en) * | 1990-02-13 | 1993-03-10 | Merck & Co. Inc. | Imidazole angiotensin ii antagonists incorporating a substituted benzyl element |
| CA2075627A1 (en) * | 1990-02-13 | 1991-08-14 | William J. Greenlee | Angiotensin ii antagonists incorporating a substituted benzyl element |
| DE4036645A1 (en) * | 1990-11-16 | 1992-05-21 | Hoechst Ag | SUBSTITUTED AZOLE, METHOD FOR THE PRODUCTION THEREOF, THE AGENT, AND THEIR USE THEREOF |
| DE4200954A1 (en) * | 1991-04-26 | 1992-10-29 | Bayer Ag | New heterocycle-substd. phenylacetic acid derivs. - are angiotensin II antagonists for treating arterial hypertonia, atherosclerosis, coronary insufficiency, ischaemic cerebral disorders, respiratory disorders, etc. |
| DE4208051A1 (en) * | 1992-03-13 | 1993-09-16 | Bayer Ag | SUBSTITUTED PHENYL ACIDIC ACID AMIDE |
-
1993
- 1993-03-26 DE DE4309968A patent/DE4309968A1/en not_active Withdrawn
-
1994
- 1994-03-14 EP EP94103881A patent/EP0622358A1/en not_active Withdrawn
- 1994-03-17 AU AU57886/94A patent/AU5788694A/en not_active Abandoned
- 1994-03-22 JP JP6073763A patent/JPH06329637A/en not_active Ceased
- 1994-03-23 NZ NZ260163A patent/NZ260163A/en unknown
- 1994-03-23 IL IL10909394A patent/IL109093A0/en unknown
- 1994-03-23 CA CA002119669A patent/CA2119669A1/en not_active Abandoned
- 1994-03-24 NO NO941073A patent/NO941073L/en unknown
- 1994-03-24 FI FI941380A patent/FI941380A7/en not_active Application Discontinuation
- 1994-03-25 HU HU9400865A patent/HUT68514A/en unknown
- 1994-03-25 ZA ZA942119A patent/ZA942119B/en unknown
- 1994-03-25 SK SK350-94A patent/SK35094A3/en unknown
- 1994-03-25 KR KR1019940006036A patent/KR940021532A/en not_active Withdrawn
- 1994-03-25 CZ CZ94710A patent/CZ71094A3/en unknown
- 1994-03-26 CN CN94103443A patent/CN1102645A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ZA942119B (en) | 1994-11-07 |
| NZ260163A (en) | 1996-02-27 |
| FI941380A0 (en) | 1994-03-24 |
| IL109093A0 (en) | 1994-06-24 |
| SK35094A3 (en) | 1995-10-11 |
| FI941380A7 (en) | 1994-09-27 |
| HU9400865D0 (en) | 1994-06-28 |
| DE4309968A1 (en) | 1994-09-29 |
| HUT68514A (en) | 1995-06-28 |
| CN1102645A (en) | 1995-05-17 |
| CZ71094A3 (en) | 1994-10-19 |
| JPH06329637A (en) | 1994-11-29 |
| EP0622358A1 (en) | 1994-11-02 |
| NO941073D0 (en) | 1994-03-24 |
| KR940021532A (en) | 1994-10-19 |
| AU5788694A (en) | 1994-09-29 |
| CA2119669A1 (en) | 1994-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69722027D1 (en) | CRYSTALS OF BENZIMIDAZOLE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF | |
| AR050917A1 (en) | COMPOUNDS BASED ON 2-AMIDO-TIAZOL THAT PRESENT INHIBITING ACTIVITY OF ENZYMES THAT USE ATP, AND COMPOSITIONS AND USES OF THE SAME | |
| LV12712A (en) | Inhibitor and sulfobutylether-7-beta-cyclodextrin or 2-hydroxypropyl-beta-cyclodekstrin and method | |
| NO20074071L (en) | Hydrazinomethyl, hydrozonomethyl and 5-membered heterocyclic compounds which act as MTOR inhibitors and their use as anti-cancer agents | |
| ATE128972T1 (en) | ISOXAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS HERBICIDES. | |
| NO941770L (en) | Substituted mono- and bipyridylmethylpyridone | |
| NO931433L (en) | 4,1-BENZOCSAZEPINE DERIVATIVES AND THEIR USE | |
| ATE127456T1 (en) | PYRIDAZINONE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF. | |
| NO975987L (en) | 4-Phenylaminothiazole derivatives, process for their preparation and pharmaceutical compositions containing said derivatives | |
| DK1113011T3 (en) | Aminotetrazole derivatives useful as nitric oxide synthase inhibitors | |
| ES2132284T3 (en) | CARBAMATE DERIVATIVES OF 2- (PIPERIDIN-4-IL, PIRIDIN-4-IL AND TETRAHIDROPIRIDIN-4-IL) -BENZOFURANE-7, THEIR PREPARATION AND USE AS ACETHYLCHOLINESTERASE INHIBITORS. | |
| FI964463A0 (en) | Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase | |
| ES2126075T3 (en) | NITROGENATED BICYCLE DERIVATIVES AS PROPIL-ENDOPEPTIDASE INHIBITORS. | |
| NO941073L (en) | Phenylglycinamide of heterocyclic substituted phenylacetic acid derivatives | |
| DK492288A (en) | AMIDE COMPOUNDS, PHARMACEUTICAL PREPARATIONS CONTAINING SAME AND PROCEDURE FOR THE PREPARATION OF THE COMPOUNDS | |
| DE69425266D1 (en) | OPTICALLY ACTIVE IMIDAZOLIDINONE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF | |
| MX2007004482A (en) | Pyridine derivatives and the preparation and the therapeutic use thereof. | |
| NO20073213L (en) | Process for the preparation of thiophene glycoside derivatives | |
| PH27293A (en) | Aryloxy arlthip heteroaryloxy heteroarylthio-alkenylene derivatives of amine and a method of use thereof | |
| TW330147B (en) | Halogenobenzimidazoles, their preparation processes and their use | |
| NO924516L (en) | ISOXAZOLYLIMIDAZOLD DERIVATIVES, PROCEDURES FOR THE PRODUCTION OF THESE, AND THEIR USE IN PHARMACEUTICALS | |
| HUT48201A (en) | Herbicide comprising anilide derivatives and process for producing such compounds | |
| BR9812928B1 (en) | 3-oxo- (2h) -1,2,4-triazine derivatives, compounds, process for preparing chemical compounds, and pharmaceutical composition. | |
| NO941519L (en) | 2-Amino-4-heteroaryl-1,4-dihydropyridines, process for their preparation and their use in pharmaceuticals | |
| EP1340753A4 (en) | CARBAMATE DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF |